Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (5): 493-497.doi: 10.3969/j.issn.1000-6621.2020.05.014
• Original Articles • Previous Articles Next Articles
ZHANG Pei-ze, ZHENG Jun-feng, CAO Wei-peng, WANG Yu-xiang, CHEN Tao, FU Liang, DENG Guo-fang()
Received:
2019-11-13
Online:
2020-05-10
Published:
2020-05-08
Contact:
DENG Guo-fang
E-mail:jxxk1035@yeah.net
ZHANG Pei-ze, ZHENG Jun-feng, CAO Wei-peng, WANG Yu-xiang, CHEN Tao, FU Liang, DENG Guo-fang. Study of the serum concentration at two time points after taking rifampicin[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 493-497. doi: 10.3969/j.issn.1000-6621.2020.05.014
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.05.014
因素 | 低浓度组(23例) | 正常浓度组(125例) | 统计值 | P值 |
---|---|---|---|---|
性别[例数(构成比,%)] | χ2=0.558 | 0.455 | ||
男 | 14(60.9) | 86(68.8) | ||
女 | 9(39.1) | 39(31.2) | ||
年龄(岁, | 36.9±4.2 | 38.2±3.5 | t=-1.585 | 0.115 |
BMI( | 21.5±4.0 | 22.9±3.7 | t=-1.647 | 0.102 |
利福平使用剂量[例数(构成比,%)] | χ2=2.442 | 0.118 | ||
450mg/d | 14(60.9) | 54(43.2) | ||
600mg/d | 9(39.1) | 71(56.8) | ||
并发糖尿病[例数(发生率,%)] | 2(8.7) | 28(22.4) | χ2=2.257 | 0.166 |
并发乙型肝炎[例数(发生率,%)] | 1(4.3) | 12(9.6) | χ2=0.669 | 0.694 |
血清白蛋白(g/L, | 42.3±4.4 | 40.9±3.2 | t=1.457 | 0.157 |
[1] |
Stott KE, Pertinez H, Sturkenboom MGG , et al. Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis. J Antimicrob Chemother, 2018,73(9):2305-2313.
doi: 10.1093/jac/dky152 URL pmid: 29701775 |
[2] |
Abulfathi AA, Decloedt EH, Svensson EM , et al. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis. Clin Pharmacokinet, 2019,58(9):1103-1129.
doi: 10.1007/s40262-019-00764-2 URL pmid: 31049868 |
[3] |
Aarnoutse RE, Kibiki GS, Reither K , et al. Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Admi-nistered at 600, 900, and 1200 Milligrams Daily in Patients with Pulmonary Tuberculosis. Antimicrob Agents Chemother, 2017,61(11):e01054-17.
doi: 10.1128/AAC.01054-17 URL pmid: 28827417 |
[4] | 赵螈, 雷倩, 党丽云 , 等. 抗结核药物血药浓度监测工作的思考和展望. 中国防痨杂志, 2017,39(11):1228-1232. |
[5] |
Mota L, Al-Efraij K, Campbell JR , et al. Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis. Int J Tuberc Lung Dis, 2016,20(6):819-826.
doi: 10.5588/ijtld.15.0803 URL pmid: 27155187 |
[6] |
Verbeeck RK, Günther G, Kibuule D , et al. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring. Eur J Clin Pharmacol, 2016,72(8):905-916.
doi: 10.1007/s00228-016-2083-4 URL pmid: 27305904 |
[7] |
Chawla PK, Udwadia ZF, Soman R , et al. Importance of Therapeutic Drug Monitoring of Rifampicin. J Assoc Physicians India, 2016,64(8):68-72.
URL pmid: 27762112 |
[8] | World Health Organization . Guideline for treatment of tuberculosis, fourth edition. Geneva:World Health Organization, 2009. |
[9] |
Alsultan A, Peloquin CA . Therapeutic drug monitoring in the treatmentof tuberculosis: an update. Drugs, 2014,74(8):839-854.
doi: 10.1007/s40265-014-0222-8 URL pmid: 24846578 |
[10] |
Vu DH, Alffenaar JW, Edelbroek PM , et al. Dried blood spots: a new tool for tuberculosis treatment optimization. Curr Pharm Des, 2011,17(27):2931-2939.
doi: 10.2174/138161211797470174 URL pmid: 21834763 |
[11] |
Pasipanodya JG, Mcilleron H, Burger A , et al. Serum drug concentrations predictive of pulmonary tuberculosis outcomes. J Infect Dis, 2013,208(9):1464-1473.
doi: 10.1093/infdis/jit352 URL |
[12] |
Wilkins JJ, Savic RM, Karlsson MO , et al. Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption. Antimicrob Agents Chemother, 2008,52(6):2138-2148.
doi: 10.1128/AAC.00461-07 URL pmid: 18391026 |
[13] |
Nahid P, Dorman SE, Alipanah N , et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis, 2016,63(7):e147-195.
doi: 10.1093/cid/ciw376 URL pmid: 27516382 |
[14] |
Kumar AKH, Chandrasekaran V, Kumar AK , et al. Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs. Indian J Med Res, 2017,145(4):530-535.
doi: 10.4103/ijmr.IJMR_552_15 URL pmid: 28862186 |
[15] |
Fahimi F, Tabarsi P, Kobarfard F , et al. Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis, 2013,17(12):1602-1606.
doi: 10.5588/ijtld.13.0019 URL pmid: 24200276 |
[16] |
Yang S, Hwang SJ, Park JY , et al. Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis. BMJ Open, 2019,9(8):e027940.
doi: 10.1136/bmjopen-2018-027940 URL pmid: 31375612 |
[17] |
邓国防, 孙丽珍, 詹森林 , 等. 有机阴离子转运多肽1B1基因多态性和利福平血药浓度对肝毒性的影响. 中国防痨杂志, 2015,37(9):933-937.
doi: doi:10.3969/j.issn.1000-6621.2015.05.004 URL |
[18] |
Requena-Méndez A, Davies G, Ardrey A , et al. Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIV. Antimicrob Agents Chemother, 2012,56(5):2357-2363.
doi: 10.1128/AAC.06059-11 URL pmid: 22330931 |
[19] | 陈明, 吴首蓉, 赵冠人 , 等. 抗结核药物利福平不同时间点血药浓度对比分析. 临床药物治疗杂志, 2018,16(5):47-49. |
[20] | 魏香兰, 方如塘, 师延峰 , 等. 抗结核药物的血药浓度监测结果分析. 中国医院药学杂志, 2015,35(11):1918-1921. |
[21] |
Dooley KE, Chaisson RE . Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis, 2009,9(12):737-746.
doi: 10.1016/S1473-3099(09)70282-8 URL |
[22] |
Kumar AK, Chandrasekaran V, Kannan T , et al. Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus. Eur J Clin Pharmacol, 2017,73(1):65-70.
doi: 10.1007/s00228-016-2132-z URL pmid: 27651240 |
[23] |
Heysell SK, Moore JL, Keller SJ , et al. Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program,Virginia,USA. Emerg Infect Dis, 2010,16(10):1546-1553.
doi: 10.3201/eid1610.100374 URL pmid: 20875279 |
[24] |
Litjens CHC, Aarnoutse RE, van Ewijk-Beneken Kolmer EWJ , et al. Protein binding of rifampicin is not saturated when using high-dose rifampicin. J Antimicrob Chemother, 2019,74(4):986-990.
doi: 10.1093/jac/dky527 URL pmid: 30597025 |
[25] | 郭少晨, 朱慧, 郭超 , 等. 909例结核病患者一线抗结核药物血药浓度监测结果分析. 中国防痨杂志, 2018,40(7):744-749. |
[1] | ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915. |
[2] | MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925. |
[3] | LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936. |
[4] | DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961. |
[5] | LI Xiao-kun, YUAN Yan-li, YANG Guang-xu, WU Yuan-yuan. Design and application of Tuberculosis Designated Hospital Information Management Platform in Changchun [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 671-675. |
[6] | LIU Guang-tian, LIU Tao, WANG Xiao-wei, LEI Juan, TIAN Xiao-mei, WANG Xiao-lin. Application of “Internet+Medical Treatment” model in tuberculosis prevention and treatment in Ningxia [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 676-681. |
[7] | WANG Ni, ZHANG Hui, ZHANG Tie-juan, CHEN Bin, LEI Juan, SUN Miao-miao, HUANG Fei. Analysis of using electronic pillbox to assist the medication management of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 682-686. |
[8] | BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing. Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724. |
[9] | ZHOU Yin-fa,ZHANG Shan-ying,DAI Zhi-song,CHEN Dai-quan,LI Wei-lin,ZHAO Yong,LIN Shu-fang. Prevalence and influencing factors of rifampicin resistance among high-risk group of drug-resistant tuberculosis in Fujian Province [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 339-344. |
[10] | FU Ting,HUANG Li-ju,YANG Jin-jun,ZHUO Yue,XIAO Hua. Psychological health status of 308 patients with MDR-PTB and its influencing factors [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 366-371. |
[11] | ZHAO Jiao-jie,FU Lei,WANG Bin,ZHANG Lei,HU Ming-hao,LU Yu. Establishment and application of pharmacodynamics and pharmacokinetics model in vitro [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 372-379. |
[12] | YAO Fang,YUAN Bao-dong,CHEN Guo-xi,LAN Xing,WANG Xiao-feng,LI Ming.. Incidence analysis of tuberculosis in household contacts of 635 new smear-positive pulmonary tuberculosis patients in Wuhan City [J]. Chinese Journal of Antituberculosis, 2020, 42(2): 164-167. |
[13] | FAN Lin,LIU Yi-dian,XIAO He-ping. Characteristics and points analysis of national Guidelines on chemotherapy of drug-resistant tuberculosis (2019) and associated consensus [J]. Chinese Journal of Antituberculosis, 2020, 42(2): 91-94. |
[14] | Maimaitiaili ·Aihemuti, HUANG Qiao-ling, Guerseman ·Abula, Renati ·Ailaiti. Analysis of drug-resistance to rifampin and isoniazid in 1307 patients with pulmonary tuberculosis in Kashi, Xinjiang [J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1209-1213. |
[15] | BAO Fang-jin, MA Dong-chun, LIU Jie, LI Zi, LI Dong-fang, ZHANG Lei, LIU Hai-qing, WU Yue, YAO Song, WANG Qing, ZHU Qing-qing. Analysis of diagnostic quality sampling survey results and influencing factors of smear negative pulmonary tuberculosis patients in hospitals at county level in Anhui province [J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1221-1226. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||